EVCM
EverCommerce Inc.
$9.20
-3.26%
$1.7B
No data for this timeframe.
Vol
Market Cap$1.7B
Cap SizeSmall Cap
Analyst ConsensusBuy (60%)
Inst. Holders7 funds
Inst. Value$8.8M
Inst. Activity2 buys / 2 sells
Insider Activity0B / 41S
Insider Net $-$3.6M
SEC Reports12
Press Releases1
Recent Activity
Jun 3, 2026
SEC
Two top executives at EverCommerce — CEO Eric Remer and President Matthew Feierstein — sold a combined $161K in open-mar
CLUSTER — Impact 3/10
Jun 3, 2026
Insider
Storey Lisa E sold 1,170 shares
Chief Legal Officer @ $9.43 ($11.0K)
Jun 3, 2026
Insider
Remer Eric Richard sold 13,522 shares
Chief Executive Officer @ $9.43 ($127.5K)
Jun 3, 2026
Insider
Remer Eric Richard sold 5,658 shares
Chief Executive Officer @ $9.57 ($54.2K)
May 26, 2026
SEC
Two EverCommerce insiders (CEO and CLO) sold a combined $162K in open-market shares over two days, a trivial amount rela
CLUSTER — Impact 2/10
May 13, 2026
SEC
CEO Eric Remer and President Matthew Feierstein sold a combined $157K in EVCM stock within a week of the Q1 2026 earning
CLUSTER — Impact 4/10
Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
20,100 shares ($243.4K)
Inst.
WELLS FARGO & COMPANY/MN — ADD
16,311 shares ($197.5K)
Price Targets
$11.21
+21.9% upside
Strong Buy
Current $9.20
Low $8.00
Median $11.00
High $14.00
7 analysts
$8.00
$14.00
Analyst Ratings
3Strong Buy
6Buy
4Hold
2Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 11, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| Mar 13, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| Mar 13, 2026 | Goldman Sachs | MAINTAIN | Sell → Sell |
| Mar 13, 2026 | RBC Capital | MAINTAIN | Sector Perform → Sector Perform |
| Mar 13, 2026 | Citizens | DOWNGRADE | Market Outperform → Market Perform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next Q | $0.19 ▲ +5.8% | $0.15 — $0.23 | 107% YoY | 5 |
| Current Q | $0.16 ▼ -5.0% | $0.12 — $0.19 | 63% YoY | 5 |
| Next FY | $0.77 | $0.58 — $0.91 | 6% YoY | 5 |
| Current FY | $0.72 ▲ +4.6% | $0.54 — $0.85 | 105% YoY | 5 |
Latest Reports
NEUTRAL
CLUSTER
3/10
Two top executives at EverCommerce — CEO Eric Remer and President Matthew Feierstein — sold a combined $161K in open-mar
Jun 3, 2026
NEUTRAL
CLUSTER
2/10
Two EverCommerce insiders (CEO and CLO) sold a combined $162K in open-market shares over two days, a trivial amount rela
May 26, 2026
MIXED
Press
6/10
EverCommerce reported Q4 2025 revenue of $151.2 million, up 5.2% YoY, and Adjusted EBITDA of $44.2 million, flat year-ov
Mar 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $4.8M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $1.8M | NEW |
| MORGAN STANLEY | $1.5M | TRIM |
| RENAISSANCE TECHNOLOGIES LLC | $243.4K | TRIM |
| WELLS FARGO & COMPANY/MN | $197.5K | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 3, 2026 | Storey Lisa | F | $11.0K |
| Jun 3, 2026 | Remer Eric | F | $127.5K |
| Jun 3, 2026 | Remer Eric | SELL | $54.2K |
| Jun 3, 2026 | Feierstein Matthew | SELL | $10.6K |
| Jun 3, 2026 | Feierstein Matthew | F | $40.3K |
7 institutional holders with $8.8M total value (726,520 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, MORGAN.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 394,053 | $4.8M | 54.2% | — |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 148,473 | $1.8M | 20.4% | NEW |
| 3 | MORGAN STANLEY | 126,625 | $1.5M | 17.4% | TRIM -31.3% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 20,100 | $243.4K | 2.8% | TRIM -49.7% |
| 5 | WELLS FARGO & COMPANY/MN | 16,311 | $197.5K | 2.2% | ADD +76.8% |
| 6 | BANK OF AMERICA CORP /DE/ | 15,795 | $191.3K | 2.2% | TRIM -42.4% |
| 7 | FMR LLC | 5,163 | $62.5K | 0.7% | DOUBLED +102.2% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 40,000 | 20,100 | -49.7% | $243.4K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 9,226 | 16,311 | +76.8% | $197.5K | 2025-Q4 |
| FMR LLC | DOUBLED | 2,554 | 5,163 | +102.2% | $62.5K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 33,359 | 0 | -100.0% | $0.00 | 2025-Q4 |
| MORGAN STANLEY | TRIM | 187,012 | 128,519 | -31.3% | $1.4M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 30,100 | 40,000 | +32.9% | $445.2K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 33,359 | — | $371.3K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 33,113 | 19,066 | -42.4% | $212.2K | 2025-Q3 |
| UBS Group AG | TRIM | 13,732 | 7,834 | -43.0% | $87.2K | 2025-Q3 |
| MORGAN STANLEY | ADD | 123,717 | 187,012 | +51.2% | $2.0M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 23,700 | 30,100 | +27.0% | $316.1K | 2025-Q2 |
| UBS Group AG | TRIM | 23,156 | 13,732 | -40.7% | $144.2K | 2025-Q2 |
| FMR LLC | TRIM | 3,962 | 2,195 | -44.6% | $23.1K | 2025-Q2 |
| UBS Group AG | TRIM | 76,225 | 23,156 | -69.6% | $233.4K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 25,850 | 15,176 | -41.3% | $153.0K | 2025-Q1 |
| FMR LLC | ADD | 2,639 | 3,962 | +50.1% | $39.9K | 2025-Q1 |
| UBS Group AG | DOUBLED | 10,084 | 76,225 | +655.9% | $839.2K | 2024-Q4 |
| CITADEL ADVISORS LLC | NEW | — | 25,850 | — | $284.6K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 7,447 | 10,553 | +41.7% | $116.2K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 167,495 | — | $1.7M | 2024-Q3 |
4 unique insiders with 41 transactions. Net insider value: -$3.6M ($0.00 bought, $3.6M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Storey Lisa E | Chief Legal Officer | F | 1,170 | $9.43 | $11.0K |
| Jun 3, 2026 | Remer Eric Richard | Chief Executive Officer | F | 13,522 | $9.43 | $127.5K |
| Jun 3, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 5,658 | $9.57 | $54.2K |
| Jun 3, 2026 | Feierstein Matthew David | President | SELL | 1,052 | $10.05 | $10.6K |
| Jun 3, 2026 | Feierstein Matthew David | President | F | 4,273 | $9.43 | $40.3K |
| Jun 2, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 13,542 | $10.53 | $142.6K |
| Jun 2, 2026 | Feierstein Matthew David | President | SELL | 10,000 | $10.53 | $105.3K |
| Jun 1, 2026 | Feierstein Matthew David | President | SELL | 10,000 | $11.26 | $112.6K |
| May 28, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 4,500 | $10.75 | $48.4K |
| May 27, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 5,974 | $10.53 | $62.9K |
| May 26, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 8,726 | $10.58 | $92.3K |
| May 22, 2026 | Storey Lisa E | Chief Legal Officer | F | 1,228 | $10.69 | $13.1K |
| May 22, 2026 | Siurek Ryan H | Chief Financial Officer | F | 1,397 | $10.69 | $14.9K |
| May 22, 2026 | Remer Eric Richard | Chief Executive Officer | F | 13,772 | $10.69 | $147.2K |
| May 22, 2026 | Feierstein Matthew David | President | F | 4,352 | $10.69 | $46.5K |
| May 21, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 3,210 | $10.23 | $32.8K |
| May 21, 2026 | Storey Lisa E | Chief Legal Officer | SELL | 4,000 | $10.38 | $41.5K |
| May 20, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 8,536 | $10.27 | $87.7K |
| May 20, 2026 | Siurek Ryan H | Chief Financial Officer | F | 399 | $10.35 | $4.1K |
| May 19, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 7,454 | $10.20 | $76.1K |
| May 14, 2026 | Siurek Ryan H | Chief Financial Officer | F | 703 | $9.53 | $6.7K |
| May 13, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 9,145 | $9.66 | $88.4K |
| May 12, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 10,055 | $10.25 | $103.1K |
| May 6, 2026 | Feierstein Matthew David | President | SELL | 5,000 | $10.83 | $54.1K |
| May 6, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 7,208 | $10.72 | $77.3K |
| May 5, 2026 | Feierstein Matthew David | President | SELL | 10,000 | $11.28 | $112.8K |
| May 5, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 11,992 | $11.17 | $134.0K |
| May 4, 2026 | Feierstein Matthew David | President | SELL | 10,000 | $11.87 | $118.7K |
| May 1, 2026 | Feierstein Matthew David | President | SELL | 10,000 | $11.94 | $119.4K |
| Apr 30, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 5,867 | $11.49 | $67.4K |
| Apr 29, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 7,766 | $11.51 | $89.4K |
| Apr 28, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 5,567 | $11.84 | $65.9K |
| Apr 23, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 5,503 | $11.55 | $63.5K |
| Apr 22, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 5,443 | $11.99 | $65.2K |
| Apr 21, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 8,254 | $12.11 | $100.0K |
| Apr 16, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 1,596 | $11.98 | $19.1K |
| Apr 15, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 5,604 | $11.96 | $67.0K |
| Apr 14, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 12,000 | $11.77 | $141.2K |
| Apr 8, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 8,700 | $11.52 | $100.2K |
| Apr 7, 2026 | Feierstein Matthew David | President | SELL | 5,000 | $11.40 | $57.0K |
| Apr 7, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 10,500 | $11.38 | $119.5K |
| Apr 6, 2026 | Feierstein Matthew David | President | SELL | 10,000 | $11.90 | $119.0K |
| Apr 2, 2026 | Feierstein Matthew David | President | SELL | 10,000 | $11.51 | $115.1K |
| Apr 1, 2026 | Feierstein Matthew David | President | SELL | 10,000 | $11.43 | $114.3K |
| Apr 1, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 7,786 | $11.42 | $88.9K |
| Mar 31, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 11,414 | $11.53 | $131.6K |
| Mar 25, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 2,703 | $11.06 | $29.9K |
| Mar 24, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 16,497 | $10.79 | $178.1K |
| Mar 18, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 2,896 | $10.04 | $29.1K |
| Mar 17, 2026 | Remer Eric Richard | Chief Executive Officer | SELL | 16,304 | $10.31 | $168.1K |
12 SEC filing reports analyzed. Sentiment: 0 bullish, 5 bearish, 0 mixed, 7 neutral. Avg impact: 3.9/10.
NEUTRAL
CLUSTER
3/10
Two top executives at EverCommerce — CEO Eric Remer and President Matthew Feierstein — sold a combin
Jun 3, 2026
NEUTRAL
CLUSTER
2/10
Two EverCommerce insiders (CEO and CLO) sold a combined $162K in open-market shares over two days, a
May 26, 2026
NEUTRAL
CLUSTER
4/10
CEO Eric Remer and President Matthew Feierstein sold a combined $157K in EVCM stock within a week of
May 13, 2026
NEUTRAL
CLUSTER
2/10
CEO Eric Remer and President Matthew Feierstein sold a total of ~$616K in EVCM stock over the 7 days
May 7, 2026
NEUTRAL
CLUSTER
2/10
Two top insiders (CEO and President) sold a combined $186K in stock over 7 days, representing a triv
May 5, 2026
NEUTRAL
PRESS-RELEASE
3/10
EverCommerce announced it will report Q1 2026 earnings on May 7, 2026, after market close, followed
Apr 17, 2026
BEARISH
CLUSTER
5/10
EverCommerce CEO Remer Eric Richard and President Matthew Feierstein sold a combined $198K in shares
Apr 16, 2026
BEARISH
CLUSTER
5/10
EverCommerce President Matthew Feierstein and CEO Eric Remer collectively sold $208K worth of shares
Apr 8, 2026
NEUTRAL
CLUSTER
3/10
EverCommerce CEO Eric Remer sold a total of 19,200 shares in the past seven days, generating approxi
Mar 12, 2026
BEARISH
CLUSTER
6/10
Multiple EverCommerce executives, including CEO Eric Remer and President Matthew Feierstein, conduct
Mar 6, 2026
BEARISH
CLUSTER
6/10
EverCommerce CEO and President executed open-market share sales totaling $666K in the past week, whi
Mar 4, 2026
BEARISH
CLUSTER
6/10
Multiple EverCommerce executives, including the CEO and President, conducted open-market share sales
Mar 3, 2026
Current analyst consensus: Buy (60% buy). Based on 15 analysts: 3 strong buy, 6 buy, 4 hold, 2 sell, 0 strong sell.
Analyst Price Targets
$11.21 mean target
+21.9% upside
Strong Buy (3.00)
$8.00 Low
$14.00 High
| Metric | Value |
|---|---|
| Current Price | $9.20 |
| Target Low | $8.00 |
| Target Mean | $11.21 |
| Target Median | $11.00 |
| Target High | $14.00 |
| # Analysts | 7 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next Q 2026-09-30 |
$0.19 | $0.15 | $0.23 | 106.9% | +5.8% | 2↑ 0↓ | $0.2B | 6.3% | 5 |
| Current Q 2026-06-30 |
$0.16 | $0.12 | $0.19 | 63.3% | -5.0% | 0↑ 5↓ | $0.2B | 2.9% | 5 |
| Next FY 2027-12-31 |
$0.77 | $0.58 | $0.91 | 6.4% | -0.5% | 3↑ 2↓ | $0.7B | 5.7% | 5 |
| Current FY 2026-12-31 |
$0.72 | $0.54 | $0.85 | 105.4% | +4.6% | 3↑ 2↓ | $0.6B | 5.1% | 5 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.164 | |
| 7d ago | $0.173 | -0.009 |
| 30d ago | $0.173 | -0.009 |
| 60d ago | $0.178 | -0.014 |
| 90d ago | $0.178 | -0.014 |
15 analyst firms have rated this stock: 0 upgrades, 5 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 11, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 13, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 13, 2026 | Goldman Sachs | MAINTAIN | Sell | Sell |
| Mar 13, 2026 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Mar 13, 2026 | Citizens | DOWNGRADE | Market Outperform | Market Perform |
| Jan 5, 2026 | RBC Capital | DOWNGRADE | Outperform | Sector Perform |
| Nov 10, 2025 | Barclays | MAINTAIN | Underweight | Underweight |
| Nov 7, 2025 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Oct 14, 2025 | Barclays | DOWNGRADE | Equal-Weight | Underweight |
| Aug 8, 2025 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Aug 7, 2025 | Oppenheimer | MAINTAIN | Outperform | Outperform |
| May 12, 2025 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| May 12, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 17, 2025 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Mar 14, 2025 | Goldman Sachs | MAINTAIN | Sell | Sell |
| Mar 14, 2025 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Mar 14, 2025 | Jefferies | MAINTAIN | Hold | Hold |
| Mar 14, 2025 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Mar 14, 2025 | Citizens Capital Markets | REITERATE | Market Outperform | Market Outperform |
| Mar 14, 2025 | Oppenheimer | MAINTAIN | Outperform | Outperform |
| Mar 12, 2025 | Citizens Capital Markets | REITERATE | Market Outperform | Market Outperform |
| Nov 13, 2024 | JMP Securities | MAINTAIN | Market Outperform | Market Outperform |
| Nov 13, 2024 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Nov 13, 2024 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Nov 13, 2024 | Oppenheimer | REITERATE | Outperform | Outperform |
| Nov 13, 2024 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Aug 7, 2024 | Deutsche Bank | MAINTAIN | Buy | Buy |
| Aug 7, 2024 | JP Morgan | MAINTAIN | Underweight | Underweight |
| Aug 7, 2024 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| May 10, 2024 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 10, 2024 | Oppenheimer | MAINTAIN | Outperform | Outperform |
| Mar 15, 2024 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Mar 15, 2024 | JMP Securities | REITERATE | Market Outperform | Market Outperform |
| Mar 15, 2024 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Mar 15, 2024 | JP Morgan | DOWNGRADE | Neutral | Underweight |
| Mar 15, 2024 | Piper Sandler | REITERATE | Neutral | Neutral |
| Mar 14, 2024 | JMP Securities | REITERATE | Market Outperform | Market Outperform |
| Nov 7, 2023 | Raymond James | MAINTAIN | Outperform | Outperform |
| Nov 7, 2023 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Nov 7, 2023 | Stifel | MAINTAIN | Buy | Buy |
| Nov 7, 2023 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Oct 11, 2023 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| Aug 8, 2023 | RBC Capital | REITERATE | Outperform | Outperform |
| Aug 8, 2023 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Aug 8, 2023 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| May 10, 2023 | Oppenheimer | MAINTAIN | — | Outperform |
| May 10, 2023 | RBC Capital | MAINTAIN | — | Outperform |
| May 10, 2023 | Goldman Sachs | MAINTAIN | — | Sell |
| May 10, 2023 | Raymond James | MAINTAIN | — | Outperform |
| Apr 24, 2023 | JMP Securities | REITERATE | — | Market Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 6 | 4 | 2 | 0 | 60% | |
| May 1, 2026 | 3 | 6 | 4 | 2 | 0 | 60% | |
| Apr 1, 2026 | 3 | 6 | 4 | 2 | 0 | 60% | |
| Mar 1, 2026 | 3 | 8 | 2 | 2 | 0 | 73% | |
| Feb 1, 2026 | 3 | 8 | 2 | 2 | 0 | 73% | |
| Jan 1, 2026 | 3 | 9 | 1 | 2 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 7, 2026
earnings_calendar
EVCM Q1 2026 Earnings After Market Close — 2026-05-07
May 4, 2026
short_interest
FTD: EVCM — 61,745 shares ($0.7M) failed to deliver
Settlement: 20260504, Price: $12.11, FTD Value: $747,731.95, EVERCOMMERCE INC COM
Apr 17, 2026
earnings
EverCommerce Announces Date of First Quarter 2026 Earnings Call
<p>DENVER, April 17, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading AI-powered platform helping service SMBs run smarter and g
Mar 12, 2026
earnings
EverCommerce Announces Fourth Quarter and Full Year 2025 Financial Results
<p align="justify">DENVER, March 12, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading AI-power
Mar 12, 2026
earnings_calendar
EVCM Q4 2025 Earnings After Market Close — 2026-03-12
Mar 10, 2026
other
DrChrono Expands AI Capabilities with Launch of EverHealth Scribe Ambient Documentation Solution
EverHealth Scribe users report saving an average of 8 minutes of clinical documentation time per visit and 32% increase in same-day claim submissions